1. Towards a science of spiritual experience

   • Harriet de Wit

   Editorial 07 July 2006 Pages: 267 - 267

2. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

   • R. R. Griffiths
   • W. A. Richards
   • R. Jesse

   Original Investigation 07 July 2006 Pages: 268 - 283

   

3. Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.

   • David E. Nichols

   Commentary 07 July 2006 Pages: 284 - 286

4. Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.

   • Solomon H. Snyder

   Commentary 07 July 2006 Pages: 287 - 288

5. Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.

   • Charles R. Schuster

   Commentary 07 July 2006 Pages: 289 - 290

6. Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.

   • Herbert D. Kleber

   Commentary 07 July 2006 Pages: 291 - 292

7. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine

   • K. Ito
   • T. Abekawa
   • T. Koyama

   Original Investigation 01 June 2006 Pages: 293 - 302

   

8. Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D₂-like receptor stimulation

   • Mireille Basselin
   • Lisa Chang
   • Stanley I. Rapoport

   Original Investigation 20 June 2006 Pages: 303 - 311

   

9. The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine

   • Robert S. Kern
   • Michael F. Green
   • Ron Marcus

   Original Investigation 30 June 2006 Pages: 312 - 320

   

10. Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABA_A receptor subtypes

    • Angela N. Duke
    • Donna M. Platt
    • James K. Rowlett

    Original Investigation 17 June 2006 Pages: 321 - 330

    

11. Paradoxical effects of prenatal acetylcholinesterase blockade on neuro-behavioral development and drug-induced stereotypies in reeler mutant mice

    • Giovanni Laviola
    • Walter Adriani
    • Flavio Keller

    Original Investigation 17 June 2006 Pages: 331 - 344

    

12. Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes

    • R. J. Rodgers
    • R. Augar
    • A. J. Tallett

    Original Investigation 27 June 2006 Pages: 345 - 355

    

13. The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements

    • Philip D. Harvey
    • Michael F. Green
    • Antony Loebel

    Original Investigation 17 June 2006 Pages: 356 - 363

    

14. Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain

    • Frederik Rode
    • Tine Broløs
    • Ole J. Bjerrum

    Original Investigation 17 June 2006 Pages: 364 - 375

    

15. A role for corticotropin-releasing factor, but not corticosterone, in acute food-deprivation-induced reinstatement of heroin seeking in rats

    • Uri Shalev
    • Peter S. Finnie
    • Priti Wahi

    Original Investigation 01 June 2006 Pages: 376 - 384

    

16. The early time course of smoking withdrawal effects

    • Peter S. Hendricks
    • Joseph W. Ditre
    • Thomas H. Brandon

    Original Investigation 03 June 2006 Pages: 385 - 396